Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous v3.6.3. This update indicates a version bump in the page's revision history.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision in the history was updated from v3.6.2 to v3.6.3. This represents a new site version rather than changes to the trial data or content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated revision label for the page history.SummaryDifference0.0%

- Check53 days agoChange DetectedThe record adds a recruitment status noting that no participants are being sought, and a new revision tag (v3.6.0) replaces the previous revision (v3.5.5) in the history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history shows that Revision: v3.5.5 was added and Revision: v3.5.4 was removed, indicating a small update to the page's version history.SummaryDifference0.0%

- Check82 days agoChange DetectedThe history now includes a new revision entry v3.5.4; the previous entry v3.5.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.